Why is Global Health falling/rising?

As of 07-Aug, Global Health Ltd's stock price is currently at 1,324.25, reflecting a decrease of 14.85 points or 1.11%. Today's performance indicates that the stock has underperformed its sector by 1.93%, following a trend reversal after two consecutive days of gains. The stock reached an intraday low of Rs 1308.8, marking a decline of 2.26%. Despite this drop, Global Health has shown strong performance over the past month with a return of 10.35%, and it has outperformed the broader market over the past year, generating an 11.37% return compared to the BSE500's negative return of -1.34%. However, the stock is facing challenges, including a significant drop in delivery volume by 28.33% against the 5-day average, which suggests falling investor participation. In the broader market context, while Global Health has demonstrated resilience with a year-to-date return of 22.27%, the recent decline may be attributed to its high valuation metrics, including a Price to Book Value of 10.5, which is considered expensive relative to its peers. The company's high management efficiency and low debt levels are positive factors, but the stock's premium valuation and a PEG ratio of 8 indicate potential overvaluation concerns. This combination of strong historical performance and current valuation pressures may be contributing to the stock's recent price decline, as investors reassess their positions in light of these factors.